Demian The Story of Emil Sinclairs Youth by Hermann Hesse
Demian The Story of Emil Sinclair's Youth by Hermann Hesse I wanted only to try to live in accord with the promptings which came from my true self
Thème : Parler du futur Niveau : fin A1 + A2 Objectifs : CO
Demain tu trouveras l'amour, demain demain toujours demain Demain la chance tournera, demain demain toujours demain Demain la vie vous sourira, demain demain toujours demain Demain on oubliera demain, quand c'est qu'arrivera demain Demain sera toujours demain, oh qu'ils sont nombreux les demains Thème : Parler du futur
Chanson : « Demain, demain » – Hk et les Déserteurs
Demain la chance _____, demain demain toujours demain Demain la vie vous _____, demain demain toujours demain Demain on _____ demain, quand c'est qu'arrivera demain Demain _____ toujours demain, oh qu'ils sont nombreux les demains Thème : Parler du futur
GLOBAL OVERVIEW OF DRUG DEMAND AND SUPPLY
3 PREFACE As the World Drug Report 2017 clearly shows, there is much work to be done to confront the many harms inflicted by drugs, to health, development, peace and security, in all regions of the world
Lesson Plan: Demain dès l’aube
Lesson Plan: Demain dès l’aube Learning objectives: - To understand and interpret a famous French poem - To learn how to use words, images and tone of voice to express different feelings and ideas - To learn how to talk about the future - To learn how to pronounce some key sounds in French Slide Activity Timings (mins) 2
Resource list: set texts and films - AQA
YouTube - presentation in English (29 mins) Voltaire: Candide BBC Radio 4 In our Time programme (42 mins) Voltaire's Candide - In Our Time BBC Radio 4 Zig Zag Education « Getting to Know zigzageducation co uk – Language Teaching Resources Dumeste, Marie-Hélène (2003) Profil d'une oeuvre : Candide ou l'optimisme, Voltaire (Hatier)
Innover pour demain - Air Liquide
La production d’une puce électronique implique jusqu’à 800 étapes, requérant environ 300 gaz et matériaux avancés EnScribe™, une famille de matériaux
Fiche 1 : réfléchir à la ville de demain
Document n°4 : des ressources sur l’approvisionnement de la ville de demain Utiliser l’énergie de la ville pour produire des légumes: www lufa com - Consulter les onglets « notre histoire » et « nos fermes » D’autres exemples de fermes verticales: Extrait du journal de France 2 du 31/07/2009 :
le FUTUR PROCHE
Demain, je au foot avec mes amis 7 Je suis fatiguée, je 8 Qu'est-ce que tu l'année prochaine ? Décris les activités de Malika, au futur proche Attention : changer noms verbes → Lundi, à dix heures, Malika va préparer son voyage à Paris
Troisième étape : inventer avec Lui demain
Troisième étape : inventer avec Lui demain Je fais silence en moi et autou de moi ; je me p épae à ce endez-vous avec le Seigneu Je me dispose à ent e et demeu e dans Sa Pésence, amou euse et bienveillante, ui m’a accompagnée, nouie Je goûte cette p ésence peut êt e disc ète mais bien vivifiante en moi
[PDF] réveiller les consciences definition
[PDF] eveiller les consciences definition
[PDF] cinétique enzymatique michaelis menten
[PDF] cinétique enzymatique michaelienne
[PDF] cinétique enzymatique tp
[PDF] vitesse de réaction enzymatique
[PDF] cinétique enzymatique pdf
[PDF] cinétique enzymatique ? deux substrats
[PDF] mise en évidence des sels minéraux dans le lait
[PDF] le lait et ses constituants st2s controle
[PDF] tp analyse du lait
[PDF] mise en evidence des protéines
[PDF] mise en évidence des sels minéraux
[PDF] c'est urgent traduction
2GLOBAL OVERVIEW OF
DRUG DEMAND AND SUPPLY
WORLD DRUG 2017This booklet constitutes the second part of the
© United Nations, May 2017. All rights reserved worldwide.ISBN: 978-92-1-148293-5
eISBN: 978-92-1-060625-7United Nations publication, Sales No. E.17.XI.8
This publication may be reproduced in whole or in part and in any form for educational or non-profit purposes without special permission from the copyright holder, provided acknowledgement of the source is made. The United Nations Office on Drugs and Crime (UNODC) would appreciate receiving a copy of any publication that uses this publication as a source.Suggested citation:
United Nations Office on Drugs and Crime,
(ISBN: 978-92-1-148291-1, eISBN: 978-92-1-060623-3, United Nations publication,Sales No. E.17.XI.6).
No use of this publication may be made for resale or any other commercial purpose whatsoever without prior permission in writing from UNODC. Applications for such permission, with a statement of purpose and intent of the reproduction, should be addressed to the Research and Trend Analysis Branch of UNODC.DISCLAIMER
The content of this publication does not necessarily reflect the views or policies of UNODC or contributory organizations, nor does it imply any endorsement. Comments on the report are welcome and can be sent to:Division for Policy Analysis and Public Affairs
United Nations Office on Drugs and Crime
PO Box 500
1400 Vienna
Austria
Tel: (+43) 1 26060 0
Fax: (+43) 1 26060 5827
E-mail: wdr@unodc.org
Website: www.unodc.org/wdr2017
3World Drug Report 2017
World Drug Report 2017
World Drug Report
WORLD DRUG REPORT 2017
4WORLD DRUG REPORT 2017
5A quarter of a billion people use drugs globally ........................................................................
...........13Problem drug use as reflected in the demand for drug treatment .........................................................15
Almost 12 million people worldwide injected drugs in 2015 ...............................................................19
HIV and hepatitis markedly impact on people who inject drugs .........................................................19
Drug use and tuberculosis .......................................................................At least 190,000 mostly preventable drug-related deaths in 2015 ........................................................26
Access to pain medication: key issues and considerations ....................................................................30
Misuse of prescription opioids ........................................................................
.....................................31Use of prescription opioids and heroin in the United States ................................................................32
Misuse of tramadol in Africa and Asia .......................................................................
..........................38 Cultivation and production .......................................................................After cannabis, cocaine accounts for the largest quantities seized .........................................................40
Drug trafficking over the darknet continues to increase at a fast pace .................................................42
Annual prevalence of drug use .......................................................................
......................................47Number and prevalence of people who inject drugs and those living with HIV ..................................49
Opium/Heroin
......50Coca/Cocaine
........58Cannabis
...............60Latest trends, cross-cutting issues
Opiates, cocaine, cannabis
Amphetamine-type stimulants, new psychoactive substancesAcknowledgements
7World Drug Report
World Drug Report
WorldDrug Report.
World Drug Report
World Drug Report
World Drug
Report
World Population Prospects: The 2015
Revision.
9 2KEY FINDINGS
WORLDREPORT 2017
10 WORLDREPORT 2017
11World Drug Report 2017
10 million years of life lost as a result of disability caused by drug u
se18 million years of life lost as a result of premature death
caused by drug use17 million DALYs attributed to drug use disorders DALYs attributed to drug use28 million
healthy years of life lost as a result of drug use17 million
healthy years of life lost as a result of drug use disorders years of "healthy" life lost as a result of disability years of life lost as a result of premature death drug usedisability prematuredeath years of life lost birthexpected life years DALYs28 million
"healthy" years of life lostWorld Drug Report
13 2GLOBAL OVERVIEW OF DRUG DEMAND AND SUPPLY
A. EXTENT OF DRUG USE
FIG. 1 Global trends in estimated number of
drug users, 2006-2015 Source: UNODC, responses to annual report questionnaire. Note: Estimates are for adults (aged 15-64) who used drugs in the past year.0.64.9
4.94.64.85.05.25.25.25.25.3
012345678
20062007
2008
2009
2010
2011
2012
2013
2014
2015
Annual prevalence among
Prevalence of people with drug use disordersPrevalence of people who use drugs26.028.027.327.127.127.327.427.428.7
29.5208 211 203 210 226 240 243 246 247255
0 50 100 150 200 250 300 350
20062007
2008
2009
2010
2011
2012
2013
2014
2015
Number of people who use drugs
millions) Number of people with drug use disordersNumber of people who use drugs0.64.9
4.94.64.85.05.25.25.25.25.3
012345678
20062007
2008
2009
2010
2011
2012
2013
2014
2015
Annual prevalence among
Prevalence of people with drug use disordersPrevalence of people who use drugs26.028.027.327.127.127.327.427.428.7
29.5208 211 203 210 226 240 243 246 247255
0 50 100 150 200 250 300 350
20062007
2008
2009
2010
2011
2012
2013
2014
2015
Number of people who use drugs
millions) Number of people with drug use disordersNumber of people who use drugsFIG. 2 Global trends in the estimated
prevalence of drug use and prevalence of people with drug use problems,2006-2015
Source: UNODC, responses to the annual report questionnaire. Note: Estimated percentage of adults (aged 15-64) who used drugs in the past year. 14WORLD DRUG REPORT 2017
The Global Burden of Disease Study 2015 examined the con nection between the use of drugs a and the development of poor health. bThe most negative health consequences of drug
use are associated with untreated hepatitis C (which can lead to liver cirrhosis and cancer) and opioid use disorders. The burden of disease is greater for health consequences related to hepatitis C than to HIV infection: considerably more deaths (222,000 from hepatitis C; 60,000 from HIV) and DALYs (6.3 million from hepatitis C; 3.0 million from HIV) are attributable to hepatitis C than to HIV. Most of those DALYs are the result of premature death, while the remainder are the result of years lived with disability. Opioids remain major drugs in terms of health consequences, with nearly 12 million of the total 17 million DALYs attrib- uted to drug use disorders in 2015 being attributed to opioid use disorders. Opioids also account for the majority of drug- related deaths in many subregions. The overall burden of disease from all causes of drug use increased in the period 2005-2015, with DALYs increasing from 24 million to 28 million, whereas the burden of disease attributed to drug use disorders alone increased from 14 million to 17 million DALYs over the same period. The largest increase in DALYs was attributed to opioid use disorders, but large increases were also attributed to disor- ders resulting from use of amphetamines and use of cocaine. The fact that opioids, including heroin, account for most of the negative health consequences of drug use is also reected in data provided by hospital emergency departments. In Europe, opioids and heroin are most frequently associated with acute toxicity presentations, with heroin involved in almost one out of four cases. Cocaine and cannabis are also prominent (each accounting for 16 per cent of presentations), with new NPS, mostly synthetic cathinones, and mephedrone in particular, accounting for 11 per cent. Polydrug use presentations are also common in Europe, being involved in 38 per cent of cases. d Number of deaths and healthy" years of life lost (DALYs) attributable to drug use, 2015 Source: Global, regional, and national comparative risk assessment of 79 behavioural, env ironmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Glo bal Burden of Disease Study 2015".Notes: Error bars represent uncertainty intervals. Numbers given in charts are percentage changes from 2005.
The Lancet
The Lancet
Hospital Emergency Presentations and Acute Drug Toxicity in Europe: Update from the Euro-DEN Plus Research Group and the EMCDDA
Percentage change from 2005
Percentage change from 2005
-25.7 -3.6 -12.0 39.019.0 29.6
49.7
67.5
23.0
2.6-27.1
-5.6 -12.3 27.512.1 22.3
37.0
quotesdbs_dbs13.pdfusesText_19